Replies to post #34922 on Amarin Corp Plc (AMRN)

[me33]

So in your opinion the Anchor trial data on label is unlikely until Reduce-It?
I wonder why FDA hates us so much. No NCE after 18 months of delays, No Anchor, SPA is thrown into a trash can, and looks like No lable compromise either.
And it's all for the safe and effective drug.